SYK

Stryker Corporation

Healthcare · $105.6B market cap

Verdict

Share price

$275.43

close of Oct 3, 2026

Fair value

$266.71

Sticker Price

Payback Price

$106.68

buy price

Fairly Valued

SYK is Fairly Valued: at $275.43 it's within 3% of its fair value of $266.71. Its buy price (Payback Price) is $106.68, 61% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth6.5% a year✗
Equity per share growth8.7% a year✗
Sales growth8.1% a year✗
Free cash flow growth8.0% a year✗
Return on invested capital10.4%✓

Follow SYK

Get notified when it reaches its buy price of $106.68. Free.

Create a free account

Superinvestors

4 of the investors we track hold SYK. In Q2 2026, 2 trimmed. Who we track

Moves in Q2 2026

Trimmed: Jensen Investment Management, AKO Capital

Insider activity

Since Jun 26, 2019: 5 open-market purchases worth $27K, 22 sales worth $118.2M and 4 other filings (stock awards, tax withholding and similar). Why purchases matter

Purchases

Sales

Other filings

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works